Tokio Marine Asset Management Co. Ltd. decreased its stake in Balchem Co. (NASDAQ:BCPC – Free Report) by 13.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,100 shares of the basic materials company’s stock after selling 500 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Balchem were worth $546,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. nVerses Capital LLC acquired a new stake in shares of Balchem during the 3rd quarter worth approximately $35,000. Bessemer Group Inc. boosted its holdings in Balchem by 568.9% during the first quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company’s stock worth $47,000 after buying an additional 256 shares in the last quarter. Blue Trust Inc. grew its position in Balchem by 642.5% during the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock valued at $148,000 after buying an additional 726 shares during the period. GAMMA Investing LLC increased its holdings in Balchem by 73.4% in the third quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock valued at $148,000 after buying an additional 356 shares in the last quarter. Finally, Private Advisor Group LLC acquired a new position in shares of Balchem in the third quarter worth about $220,000. 87.91% of the stock is currently owned by hedge funds and other institutional investors.
Balchem Stock Up 0.5 %
Shares of NASDAQ BCPC opened at $177.77 on Friday. The firm has a market cap of $5.78 billion, a price-to-earnings ratio of 47.79, a price-to-earnings-growth ratio of 5.30 and a beta of 0.65. The company’s 50-day simple moving average is $172.71 and its 200-day simple moving average is $165.59. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. Balchem Co. has a 52-week low of $120.76 and a 52-week high of $186.03.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on BCPC
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Recommended Stories
- Five stocks we like better than Balchem
- How to Use Stock Screeners to Find Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Technology Stocks Explained: Here’s What to Know About Tech
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Retail Stocks Investing, Explained
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.